Some people find that gut health support strategies like probiotics and ginger tea ease the transition
Others will want to switch immediately
This is typically 12 to 18 months from the manufacturing date, though some batches extend further depending on stability testing
The MHRA has issued repeated safety alerts about the risks of purchasing unlicensed injectable peptides including GLP-1 receptor agonists and weight-loss injections from unregulated online sources, citing concerns about: Uncertain purity and potency of preparations not manufactured under GMP conditions Absence of validated stability data , including reconstituted shelf life and beyond-use dates Risk of microbial contamination in preparations made outside licensed aseptic facilities Mislabelling, adulteration, or counterfeit products sold through unregulated channels NICE guidance on pharmacotherapy for obesity currently covers licensed agents only
Paired with expert health coaching and personalized nutritional guidance, this new generation of medication can do more than help you reach and sustain a healthier weight
Other GLP-1 Medications: Less Common Alternatives: Liraglutide (Saxenda): Daily injection (not weekly) Less effective than semaglutide or tirzepatide Average 5-8% weight loss More expensive than newer options Rarely recommended now that better options exist Dulaglutide (Trulicity): Weekly injection Primarily for diabetes, not weight loss Less effective for weight loss than semaglutide/tirzepatide Not typically prescribed for weight loss These older medications have largely been superseded by more effective semaglutide and tirzepatide options
